<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04697121</url>
  </required_header>
  <id_info>
    <org_study_id>0921/22052019</org_study_id>
    <nct_id>NCT04697121</nct_id>
  </id_info>
  <brief_title>Artichoke and Bergamot Phytosome</brief_title>
  <official_title>Artichoke and Bergamot Phytosome: a Randomized Double Blind Clinical Trial in Bergamot Poor-responders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda di Servizi alla Persona di Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda di Servizi alla Persona di Pavia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to WHO data, about 50% of deaths each year are caused by cardiovascular disease.&#xD;
      One of the strategies for prevention of cardiovascular diseases, in addition to a correct&#xD;
      lifestyle, is to implement therapies that reduce the level of cholesterol in the blood and at&#xD;
      the same time control the glycemic levels, which are closely related in the maintenance of&#xD;
      metabolic homeostasis. The aim of this clinical study is to confirm the potential broader&#xD;
      activity as hypocholesterolemic agent in bergamot poor-responders subjects with mild&#xD;
      hypercholesterolemia. The study was a 8-week randomized double-blind placebo-controlled&#xD;
      trial. Participants were randomized to either the supplement based on dry extract from&#xD;
      artichoke leaf and bergamot phospholipid (31) or placebo arm (29).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 21, 2019</start_date>
  <completion_date type="Actual">July 16, 2020</completion_date>
  <primary_completion_date type="Actual">July 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of lipid parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Total cholesterol, LDL cholesterol, HDL cholesterol (mg/dl)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of lipid parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>apolipoprotein A, apolipoprotein B, triglycerides (mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of metabolic parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Fasting blood glucose (mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of metabolic parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Glycated Hemoglobin (percent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of anthropometric measurements</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Weight (kg) and height (m) were combined to report BMI in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of anthropometric measurements</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>waist circumference (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of body composition</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Fat mass (g), Fat Free Mass (g), Visceral Adipose Tissue (g)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of safety parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Aspartate Aminotransferase (UI/l), Alanine Aminotransferase (UI/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of safety parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Gamma Glutamyl Transferase (U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of safety parameters</measure>
    <time_frame>Baseline / 30 days / 60 days</time_frame>
    <description>Creatinine (mg/dl)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Bergamot Phytosome and Artichoke leaf dry extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>600 mg of Bergamot Phytosome and 100 mg of Artichoke leaf standardized dry extract</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Combined Bergamot phytosome and Artichoke leaf dry extract</intervention_name>
    <description>600 mg of Bergamot Phytosome and 100 mg of Artichoke leaf standardized dry extract. Supplementation regimen was 2 daily tablets, one before lunch and one before dinner, for 8 continuous weeks.</description>
    <arm_group_label>Combined Bergamot Phytosome and Artichoke leaf dry extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Supplementation regimen was 2 daily tablets, one before lunch and one before dinner, for 8 continuous weeks.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  mild hypercholesterolemia (220 - 280 mg/dl)&#xD;
&#xD;
          -  subjects were not taking any medication likely to affect lipid metabolism (such as&#xD;
             statins)&#xD;
&#xD;
          -  subjects were bergamot poor-responders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  liver, renal and thyroid diseases&#xD;
&#xD;
          -  history of cardiovascular disease (CVD)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda di Servizi alla Persona</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 29, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bergamot</keyword>
  <keyword>Cynara cardunculus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

